These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9194115)

  • 21. A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
    Kline MW; Dunkle LM; Church JA; Goldsmith JC; Harris AT; Federici ME; Schultze ME; Woods L; Loewen DF; Kaul S
    Pediatrics; 1995 Aug; 96(2 Pt 1):247-52. PubMed ID: 7630678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of late-state HIV infection.
    Millard PS
    J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
    [No Abstract]   [Full Text] [Related]  

  • 23. Pediatric HIV infection: a primer for pharmacists.
    Cohen LG; Noormohamed SE
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):580-95. PubMed ID: 8908935
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease. A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children.
    Zaknun D; Orav J; Kornegay J; al-Attar I; Fuchs D; Zaknun J; Wachter H; Chatis P; Burchett SK; McIntosh K
    J Pediatr; 1997 Jun; 130(6):898-905. PubMed ID: 9202611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse transcriptase mutations in HIV-1-infected children treated with zidovudine.
    Unal A; Lorenzo E; Brown M; Smith L; Matsuura S; Scott G; Scott W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):140-5. PubMed ID: 8862278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.
    Albrecht MA; Hughes MD; Liou SH; Katzenstein DA; Murphy R; Balfour HH; Para MF; Valdez H; Hammer SM;
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1337-44. PubMed ID: 11018853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.
    Kline MW; Van Dyke RB; Lindsey JC; Gwynne M; Culnane M; McKinney RE; Nichols S; Mitchell WG; Yogev R; Hutcheon N
    Pediatrics; 1998 Feb; 101(2):214-20. PubMed ID: 9445494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and tolerance of a combination of AZT, DDC, and saquinavir in patients infected with the human immunodeficiency virus].
    Soriano Vázquez V; Rodríguez-Rosado Martínez-Echevarría R; Jiménez-Nacher I; Valencia Ortega E; Moreno Celda V; González-Lahoz J
    Rev Clin Esp; 1998 Sep; 198(9):634-5. PubMed ID: 9803794
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 32. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
    J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Initial anti-retroviral treatment (therapeutic approach to patients without previous treatment)].
    Gatell JM; Guerra L; Pérez-Elías MJ; Santamaría JM
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():20-3. PubMed ID: 9053022
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
    Montaner JS; DeMasi R; Hill AM
    AIDS; 1998 Mar; 12(5):F23-8. PubMed ID: 9543436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life.
    Scott-Lennox JA; Mills RJ; Burt MS
    Ann Pharmacother; 1998 May; 32(5):525-30. PubMed ID: 9606471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy for human immunodeficiency virus infection -- what have we learned?
    Corey L; Holmes KK
    N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study.
    ;
    AIDS; 1999 Jan; 13(1):57-65. PubMed ID: 10207545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
    Sölder B; Wintergerst U; Notheis G; Eberle J; Gürtler L; Belohradsky BH
    J Pediatr; 1997 Feb; 130(2):293-9. PubMed ID: 9042135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.